Table 3: Summary table of critical effects and current regulation on selected coformulants (Tabel 3: Oversigtstabel over kritiske effekter og gældende regulering af udvalgte hjælpestoffer) Chemical name Acronym Critical effects EU- classification^a,1) OEL DK²⁾ C-value³⁾ Manganese (II) sulphate Manganese (II) sulphide Neurological effects: LOAEC humans 0.14-1.59 mg Mn/m³ as total dust Xn; R48/20/22 N; R51/53 - 0.2 mg Mn/m³ (inorganic compounds) 0.001 mg Mn/m³ (inorganic dust) Diammonium sulphate Lung: LOAEC rat 0.5-1 mg/m³ - - - Dimethyl ether DME Acute: CNS depression humans RDT: Liver NOEC rat 380 mg/m³ Fx; R12 1000 ppm (1885 mg/m³) 1 mg/m³ Hexamethylenetetramine Sensitisation inhalation, skin contact F; R11 R42/43 - - 1-Methyl-1,2-ethanediyl dioleate No data available - - - Isopropyl myristate Irritation skin, respiratory tract - - - Sodium ligninsulphonate Irritation eye, skin, respiratory tract - - - Calciumdodecylbenzene- sulphonate CaDBS Possibly irritation eye, skin, respiratory tract - by analogy with LAS - - - Ethylene glycol EG Kidney: NOAEL rat 200 mg/kg b.w./day Developmental effects: NOAEC mouse 1000 mg/m³ Irritation respiratory tract: LOAEC human 17 mg/m³ Xn; R22 10 ppm (26 mg/m³) - Propylene glycol PG Skin and mucous membrane irritation/dehydration - - - 2-Butoxyethanol EGBE Haemolysis: NOEC human above 3 mg/m³ Irritation eye, skin Irritation respiratory tract: NOAEC human above 100 mg/m³ Xn; R20/21/22 Xi; R36/38 20 ppm (98 mg/m³) 0.04 mg/m³ L 1-Methoxy-2-propanol 2PG1ME Irritation eye, mucous membranes, respiratory tract - 50 ppm (300 mg/m³) skin notation 1 mg/m³ Diethylene glycol mono-n-butyl ether DEGBE Irritation skin, eye RDT: skin irritation NOAEL 100-200 rat mg/kg b.w./day Xi; R36 100 mg/m³ 0.02 mg/m³ L Dipropylene glycol monomethyl ether DPGME Eye and mucous membrane irritation - 50 ppm (300 mg/m³) skin notation 1 mg/m³ Polyethyleneglycol dodecylether polyEGDE Skin and eye irritation - - -